A Hybrid Satellite Symposium during the 2023 AAAAI Annual Meeting
Friday, February 24, 2023
Registration and Reception
6:30 PM – 7:00 PM CST
Symposium and Panel Discussions
7:00 PM – 8:30 PM CST
Grand Hyatt San Antonio River Walk
Lone Star A, Second Floor
600 E. Market Street
San Antonio, Texas 78205
Also Available to Virtual Attendees via Online Simulcast
FACULTY
Bob Geng, MD
Voluntary Associate Clinical Professor, Allergy & Immunology
Co-Director, AAFA-sponsored Severe Asthma Program
Rady Children's Hospital
Allergy/Immunology Director, Multidisciplinary Atopic Dermatitis Program
University of California San Diego
President, San Diego Allergy Society
San Diego, CA
Lauren Loop
Eczema Educator/Lead Clinical Research Coordinator
Rady Children’s Hospital
Director, Grants and Rare Disease
Allergy and Asthma Medical Group and Research Center
Executive Director, San Diego Allergy Society
San Diego, CA
Reid Oldenburg, MD, PhD
Assistant Professor, Department of Dermatology
University of California San Diego
San Diego, CA
Katie Smiley, PA-C
Clinic Coordinator, Multidisciplinary Atopic Dermatitis Program
Rady Children’s Hospital
San Diego, CA
Atopic dermatitis (AD) typically manifests in infancy and is often the first presenter in a series of type 2 inflammatory diseases commonly referred to as “the atopic march”. While novel therapies have been recently made available for adults and teens, the treatment landscape for infants and children is finally catching up. In this multidisciplinary, interprofessional panel featuring allergists, dermatologists, physicians, a PA, eczema educator, and a parent/guardian of a child with AD, experts will discuss the pathophysiology of AD, new and emerging biologics for pediatric AD, and how to approach AD management with an effective team-based strategy. Attend in-person or via simulcast.
PROGRAM AGENDA
Type 2 Inflammation in Atopic Dermatitis and the Atopic March
Current and Emerging Biologics for Moderate-to-Severe Atopic
Dermatitis in Children
Interprofessional Management of Comorbidities in Children with
Moderate-to-Severe Atopic Dermatitis
WHO SHOULD ATTEND?
Dermatologists, allergists/clinical immunologists, and pediatric clinicians
LEARNING OBJECTIVES FOR ATTENDEES
Upon completion of this symposium, participants should be better able to:
- Identify the role of type 2 inflammation in the pathogenesis of moderate-to-severe atopic dermatitis (AD) and other atopic diseases
- Apply key data on available and emerging biologic therapies for the treatment of moderate-to-severe AD in children
- Integrate the unique roles and responsibilities of the interprofessional care team when managing common comorbidities in children with moderate-to-severe AD
PROVIDER STATEMENT
This educational activity was independently developed by RMEI Medical Education, LLC. All faculty and planner relevant financial relationships were identified and mitigated and RMEI Medical Education, LLC has reviewed the content and determined it to be fair, balanced, and without commercial bias.
SUPPORTER STATEMENT
This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.
Disclosure of Financial Relationships
RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy. RMEI will disclose to learners the presence or absence of relevant financial relationships for all persons in control of content before the learner engages in the education.
Americans WIth Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact RMEI prior to the live event at (866) 770-RMEI.
FEE INFORMATION
There is no fee for this educational activity.
This program is not certified for continuing education credit.
The content and opinions expressed are those of the provider and/or presenter(s) and are not necessarily those of the AAAAI.
FOLLOW RMEI
Additional educational activities offered by RMEI Medical Education, LLC can be found
at www.RMEI.com or by calling toll-free (866) 770-RMEI.